Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Philip McGlave"'
Autor:
Peter A. Cassileth, Philip McGlave
Publikováno v:
Hospital Practice. 35:43-56
When an HLA-matched sibling is not available and nontransplant approaches have been ineffective, transplantation of hematopoietic stem cells from an unrelated donor can effect a cure in some patients with chronic myelogenous leukemia. Even when succe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fc0686e998570d8c00091e2f0fd5b44
https://doi.org/10.3810/hp.2000.08.209
https://doi.org/10.3810/hp.2000.08.209
Autor:
Trish Sigley, Kenneth V. I. Rolston, Robert P. Witherspoon, Judy Beach Campbell, Philip McGlave
Publikováno v:
Cancer Practice. 6:202-205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db46c496219b2872433277522dee8e36
https://doi.org/10.1046/j.1523-5394.1998.006004202.x
https://doi.org/10.1046/j.1523-5394.1998.006004202.x
Autor:
Philip McGlave
Publikováno v:
Hematology (Amsterdam, Netherlands). 10
Over the last quarter century investigators have demonstrated that allogeneic hematopoietic cell transplantation (HCT) can cure chronic myelogenous leukemia (CML). Early reports suggested the efficacy of related donor transplant after a myeloablative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a1391cee29826fb344fde93dd6167f5
https://pubmed.ncbi.nlm.nih.gov/16188624
https://pubmed.ncbi.nlm.nih.gov/16188624
Autor:
Daniel J. Weisdorf, Auayporn Nademanee, Michael Haagenson, Joseph H. Antin, Mary M. Horowitz, Effie Petersdorf, Carolyn Hurley, Philip McGlave, Craig Kollman, George Selby, Mukta Arora, Nancy A. Kernan, Stephen R. Spellman, John P. Klein
Publikováno v:
Blood. 110:171-171
Current criteria for the selection of adult volunteer unrelated donors (URD) include matching for HLA alleles determined by high resolution typing methods. However, the impact of URD matching for 8/8 HLA alleles (HLA-A, B, C, DRB1) on survival compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9042e3285839846650034f08fe41aac
https://doi.org/10.1182/blood.v110.11.171.171
https://doi.org/10.1182/blood.v110.11.171.171
Publikováno v:
Hematology/Oncology Clinics of North America. 12:xi-xii
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb30e1bd9044eee9017eefb48b6b386
https://doi.org/10.1016/s0889-8588(05)70494-9
https://doi.org/10.1016/s0889-8588(05)70494-9
Autor:
Noel Laudi, Mukta Arora, Linda Burns, Philip McGlave, Jeffrey Miller, Gerald Bohac, Tyson Rogers, Juliet Barker, James Coad, Daniel Weisdorf
Publikováno v:
American Journal of Hematology; Jul2006, Vol. 81 Issue 7, p519-524, 6p
Autor:
Joseph J. Mazza, David P. Harrington, Martin M. Oken, Peter A. Cassileth, John Hines, Philip McGlave, Michael J. O'Connell, John M. Bennett
Publikováno v:
Journal of Clinical Oncology. 6:583-587
The value of maintenance therapy after the achievement of complete remission in adult acute nonlymphocytic leukemia (ANLL) has never been clearly established. A randomized Eastern Cooperative Oncology Group (ECOG) study of postremission therapy compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d88f449a5d0646eab0d4af993c5926
https://doi.org/10.1200/jco.1988.6.4.583
https://doi.org/10.1200/jco.1988.6.4.583
Autor:
Philip McGlave
Publikováno v:
Hospital practice (Office ed.). 20(11)
The advances in bone marrow transplantation that have been incorporated into standard practice in treatment of several types of leukemia have been remarkable, although transplantation is still accompanied by a multitude of risks and complications. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940873d4a36a372a39da0e5fc7ab5372
https://pubmed.ncbi.nlm.nih.gov/2997246
https://pubmed.ncbi.nlm.nih.gov/2997246